Trade IOVA stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Iovance Biotherapeutics, Inc. (IOVA) is trading at US$14.52, down 0.31% today as of Oct 13, 11:50 EDT. The company has a market capitalisation of US$3.76B. Over the past 52 weeks, IOVA has traded between US$1.76 and US$15.30. On Syfe you can trade IOVA with $0 commission and add it to your watchlist.
| Previous close | US$14.56 |
|---|---|
| Market cap | US$3.76B |
| 52-week range | US$1.76 – US$15.30 |
| Volume | 8.84M |
| Exchange | US |
Iovance Biotherapeutics, Inc.
Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.
Year: 2010
Iovance Biotherapeutics, Inc. (IOVA) stock is trading at US$14.52, -0.31% from the previous close of US$14.56.
The market cap for Iovance Biotherapeutics, Inc. (IOVA) stock is approximately US$3.76B.
The 52-week high for Iovance Biotherapeutics, Inc. (IOVA) stock is US$15.30.
The 52-week low for Iovance Biotherapeutics, Inc. (IOVA) stock is US$1.76.
Iovance Biotherapeutics, Inc. (IOVA) does not currently pay a dividend.
Stay on top of IOVA
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
